Abstract:Objetive: To explore the clinical and genetic characteristics of two children with Neurodevelopmental disorders (NDDs) due to variants of TANC2 gene. Methods: Clinical data of two children who were admitted to the Third Affiliated Hospital of Zhengzhou University respectively in April 2020 and April 2021 were retrospectively analyzed. Peripheral blood samples of the children and their parents were collected and subjected to whole exome sequencing. Candidate variants were verified by Sanger sequencing. By using "TANC2 gene", "Neurodevelopmental disorders", "Nervous system development disorders", "TANC2" as the key words, similar cases were searched from the CNKI, Wanfang database platform and PubMed database, with the search time set as from the establishment of the database to December 2023. This study was approved by the Third Affiliated Hospital of Zhengzhou University (Ethics No. 2020-57). Results: Case 1 was a 1-year-and-3-month-old girl who had developed convulsions at 1 year old and had three episodes of seizures. Her epilepsy had resolved with the treatment of oxcarbazepine, which was stopped at the age of 2-year-and-7-month. Her language, movement and intelligence development were all normal. Case 2 was a 1-year-and-10-month-old boy, who had developed convulsions at 1 year old. His seizure type was myoclonus, and the frequency was dozens of times a day. His epilepsy had resolved with the treatment of sodium valproate. His language, movement and intelligence development was delayed for about half a year. Genetic analysis showed that both children had harbored novel variants of the TANC2 gene (NM_025185.4), including c.3398G>A (p.Gly1133Glu) and c.2829+1G>A, respectively. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the former was rated as likely pathogenic (PS2+PM2_Supporting+PP3) and the latter was rated as pathogenic (PVS1+PS2+PM2_Supporting). Two previous reports were retrieved, which had involved 17 cases and 16 variants. Common features had included autism spectrum disorder (70.6%, 12/17) , intellectual disability (94.1%,16/17) , language and motor retardation (88.2%, 15/17；58.8%, 10/17), facial dysmorphism, epilepsy, ataxia, and thoracic and spinal deformities. Conclusion: Variants of the TANC2 gene probably underlay the epilepsy and development delay in these children with NDDs.

Exploring the clinical spectrum of CNTNAP2-related neurodevelopmental disorders: A case series and a literature appraisal

Hyperkinetic stereotyped movements in a boy with biallelic CNTNAP2 variants

Somatic Variants in New Candidate Genes Identified in Focal Cortical Dysplasia Type II

Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C

Case Report: A Case of Epileptic Disorder Associated With a Novel CNTN2 Frameshift Variant in Homozygosity due to Maternal Uniparental Disomy

KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties

CNKSR2-related neurodevelopmental and epilepsy disorder: a cohort of 13 new families and literature review indicating a predominance of loss of function pathogenic variants

Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay

Expanding the Mutational Landscape and Clinical Phenotype of CHD2-Related Encephalopathy

Novel NALCN variant linked to temporal lobe epilepsy

KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases

Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants

A Novel CNTNAP2 Mutation Results in Abnormal Neuronal E/I Balance

[Clinical and genetic analysis of two children with TANC2 gene variants and a literature review]

Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder

CIC-Related Neurodevelopmental Disorder: A Review of the Literature and an Expansion of Genotype and Phenotype

Novel and known minor alleles of CNTNAP2 gene variants are associated with comorbidity of intellectual disability and epilepsy phenotypes: a case–control association study reveals potential biomarkers

Identification of a novel KCNT2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review

Familial KCNQ2 mutation: a psychiatric perspective

Clinical Study of 30 Novel KCNQ2 Variants/Deletions in KCNQ2-Related Disorders.

Case Report: Causative De Novo Variants of KCNT2 for Developmental and Epileptic Encephalopathy